 | • レポートコード：QYR9ST03381 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、進行腎細胞癌治療薬の世界市場について調査・分析し、進行腎細胞癌治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（放射線療法、化学療法、ホルモン療法、治験療法）、用途別（病院、癌研究所、外来手術センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の進行腎細胞癌治療薬市場動向 ・主要企業別マーケットシェア ・進行腎細胞癌治療薬の種類別市場規模2014-2019 （放射線療法、化学療法、ホルモン療法、治験療法） ・進行腎細胞癌治療薬の用途別市場規模2014-2019 （病院、癌研究所、外来手術センター、その他） ・進行腎細胞癌治療薬の北米市場：主要企業・種類別/用途別市場規模 ・進行腎細胞癌治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・進行腎細胞癌治療薬の中国市場：主要企業・種類別/用途別市場規模 ・進行腎細胞癌治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・進行腎細胞癌治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・進行腎細胞癌治療薬のインド市場：主要企業・種類別/用途別市場規模 ・進行腎細胞癌治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Acceleron Pharma、Argos Therapeutics、AVEO Pharmaceuticals、Bayer、Bristol-Myers Squibb Company、Eisai、Exelixi、Genentech、Immatics Biotechnologies、Merck、Novartis、Ono Pharmaceutical、Pfizer、Rexahn Pharmaceuticals、Hoffmann-La Roche） ・進行腎細胞癌治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell carcinoma is the most common type of kidney cancer in adults that represents nearly 2-3% of all cancer cases in adults. The disorder is asymptomatic in advanced renal cell carcinoma at initial stages that results with people often in the advanced stages of the disease by the time it is discovered. The initial symptoms of renal cell carcinoma are a general feeling of being unwell, hypertension, flank pain, weight loss, fever, blood in the urine, night sweats, and a mass in the abdomen. Management of renal cell carcinoma has seen significant development in the past few years, and new approaches are being established. Advanced renal cell carcinoma is a disease that normally cannot be treated by general therapy and is challenging to treat. Surgical removal of one or both kidneys should be considered in patients who suffer from metastatic disease before systemic therapy.Increase in aging population is one of the major factors driving the revenue growth of the renal cell carcinoma market. Furthermore, renal cell carcinoma is a rare disease with a small patient-base constitutingall ages from infants to older adults. However, the disease is predominantly noted in age group of ~ 60-70 years, exposing a higher probability of occurrence. Expanding research into orphan drugs is a factor projected to create lucrative revenue potential for drug makers of renal cell carcinoma.
Restraints include lack of technological advances in genome sequencing, stagnant number of diagnosed population base and low patient awareness levels among others.The disease pattern of renal cell carcinoma disease is also affected by the genomic alteration, changes in lifestyle etc. Other inevitable restraints include lack of product availability on specific diseases & target indications apart from feeble pipeline.
In 2018, the global Advanced Renal Cell Carcinoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Advanced Renal Cell Carcinoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Advanced Renal Cell Carcinoma Therapeutics development in United States, Europe and China.
The key players covered in this study
Acceleron Pharma
Argos Therapeutics
AVEO Pharmaceuticals
Bayer
Bristol-Myers Squibb Company
Eisai
Exelixi
Genentech
Immatics Biotechnologies
Merck
Novartis
Ono Pharmaceutical
Pfizer
Rexahn Pharmaceuticals
Hoffmann-La Roche
Market segment by Type, the product can be split into
Radiation Therapy
Chemotherapy
Hormone Therapy
Investigational Therapy
Market segment by Application, split into
Hospitals
Cancer Research Institutes
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Advanced Renal Cell Carcinoma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Advanced Renal Cell Carcinoma Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Advanced Renal Cell Carcinoma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Radiation Therapy
1.4.3 Chemotherapy
1.4.4 Hormone Therapy
1.4.5 Investigational Therapy
1.5 Market by Application
1.5.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Cancer Research Institutes
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Advanced Renal Cell Carcinoma Therapeutics Market Size
2.2 Advanced Renal Cell Carcinoma Therapeutics Growth Trends by Regions
2.2.1 Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions (2014-2025)
2.2.2 Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Advanced Renal Cell Carcinoma Therapeutics Market Size by Manufacturers
3.1.1 Global Advanced Renal Cell Carcinoma Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Advanced Renal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Advanced Renal Cell Carcinoma Therapeutics Key Players Head office and Area Served
3.3 Key Players Advanced Renal Cell Carcinoma Therapeutics Product/Solution/Service
3.4 Date of Enter into Advanced Renal Cell Carcinoma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2014-2019)
4.2 Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Advanced Renal Cell Carcinoma Therapeutics Market Size (2014-2019)
5.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in United States
5.3 United States Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
5.4 United States Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
6 Europe
6.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size (2014-2019)
6.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in Europe
6.3 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
6.4 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
7 China
7.1 China Advanced Renal Cell Carcinoma Therapeutics Market Size (2014-2019)
7.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in China
7.3 China Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
7.4 China Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
8 Japan
8.1 Japan Advanced Renal Cell Carcinoma Therapeutics Market Size (2014-2019)
8.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in Japan
8.3 Japan Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
8.4 Japan Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size (2014-2019)
9.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
9.4 Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
10 India
10.1 India Advanced Renal Cell Carcinoma Therapeutics Market Size (2014-2019)
10.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in India
10.3 India Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
10.4 India Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size (2014-2019)
11.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in Central & South America
11.3 Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
11.4 Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application
12 International Players Profiles
12.1 Acceleron Pharma
12.1.1 Acceleron Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.1.4 Acceleron Pharma Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.1.5 Acceleron Pharma Recent Development
12.2 Argos Therapeutics
12.2.1 Argos Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.2.4 Argos Therapeutics Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.2.5 Argos Therapeutics Recent Development
12.3 AVEO Pharmaceuticals
12.3.1 AVEO Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.3.4 AVEO Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.3.5 AVEO Pharmaceuticals Recent Development
12.4 Bayer
12.4.1 Bayer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.4.4 Bayer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.4.5 Bayer Recent Development
12.5 Bristol-Myers Squibb Company
12.5.1 Bristol-Myers Squibb Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.5.4 Bristol-Myers Squibb Company Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.5.5 Bristol-Myers Squibb Company Recent Development
12.6 Eisai
12.6.1 Eisai Company Details
12.6.2 Company Description and Business Overview
12.6.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.6.4 Eisai Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.6.5 Eisai Recent Development
12.7 Exelixi
12.7.1 Exelixi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.7.4 Exelixi Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.7.5 Exelixi Recent Development
12.8 Genentech
12.8.1 Genentech Company Details
12.8.2 Company Description and Business Overview
12.8.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.8.4 Genentech Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.8.5 Genentech Recent Development
12.9 Immatics Biotechnologies
12.9.1 Immatics Biotechnologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.9.4 Immatics Biotechnologies Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.9.5 Immatics Biotechnologies Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
12.10.4 Merck Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
12.10.5 Merck Recent Development
12.11 Novartis
12.12 Ono Pharmaceutical
12.13 Pfizer
12.14 Rexahn Pharmaceuticals
12.15 Hoffmann-La Roche
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Advanced Renal Cell Carcinoma Therapeutics Key Market Segments
Table Key Players Advanced Renal Cell Carcinoma Therapeutics Covered
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Market Share by Type 2014-2025
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Hormone Therapy Figures
Table Key Players of Hormone Therapy
Figure Investigational Therapy Figures
Table Key Players of Investigational Therapy
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Cancer Research Institutes Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Advanced Renal Cell Carcinoma Therapeutics Report Years Considered
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions 2014-2019
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions 2014-2019
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Advanced Renal Cell Carcinoma Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Manufacturers in 2018
Table Global Advanced Renal Cell Carcinoma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Advanced Renal Cell Carcinoma Therapeutics Product/Solution/Service
Table Date of Enter into Advanced Renal Cell Carcinoma Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Type (2014-2019)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Application (2014-2019)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Application in 2018
Figure United States Advanced Renal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table United States Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table United States Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure Europe Advanced Renal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure China Advanced Renal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table China Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table China Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure Japan Advanced Renal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table Japan Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table Japan Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure India Advanced Renal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table India Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table India Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Table Acceleron Pharma Company Details
Table Acceleron Pharma Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019) (Million US$)
Figure Acceleron Pharma Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table Acceleron Pharma Recent Development
Table Argos Therapeutics Company Details
Table Argos Therapeutics Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Argos Therapeutics Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table Argos Therapeutics Recent Development
Table AVEO Pharmaceuticals Company Details
Table AVEO Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure AVEO Pharmaceuticals Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table AVEO Pharmaceuticals Recent Development
Table Bayer Company Details
Table Bayer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Eisai Company Details
Table Eisai Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table Eisai Recent Development
Table Exelixi Company Details
Table Exelixi Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Exelixi Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table Exelixi Recent Development
Table Genentech Company Details
Table Genentech Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table Genentech Recent Development
Table Immatics Biotechnologies Company Details
Table Immatics Biotechnologies Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Immatics Biotechnologies Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table Immatics Biotechnologies Recent Development
Table Merck Company Details
Table Merck Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Ono Pharmaceutical Company Details
Table Pfizer Company Details
Table Rexahn Pharmaceuticals Company Details
Table Hoffmann-La Roche Company Details
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Regions in 2025
Figure United States Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Product (2019-2025)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Product in 2025
Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2019-2025)
Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
基底細胞癌治療の世界市場：市場規模・現状・予測 Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…- 多発性骨髄腫用るCAR T細胞療法の世界市場：市場規模・現状・予測 CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- 犬幹細胞療法の世界市場：市場規模・現状・予測 The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 多発性硬化症向け幹細胞療法の世界市場：市場規模・現状・予測 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 細胞治療の世界市場：市場規模・現状・予測 Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.Cell…